T cell priming versus T cell tolerance induced by synthetic peptides

Journal of Experimental Medicine

Volumn 182, Issue 1, 1995, Pages 261-266

  Aichele, Peter ^a   Brduscha Riem, Karin ^a   Zinkernagel, Roll M ^a   Hengartner, Hans ^a   Pircher, Hanspeter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE INDUCTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTIGENS, VIRAL; EPITOPES; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNIZATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; THYMECTOMY;

EID: 0029006188     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.1.261     Document Type: Article

References (54)

1. Mitchison, N.A. 1964. Induction of immunological paralysis in two zones of dosage. Roy. Soc. Proc. 161: 275-292.
2. Dresser, D.W. 1962. Specific inhibition of antibody production: II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology. 5: 378-388.
3. Chiller, J.M., G.S. Habicht, and W.O. Weigle. 1971. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (Wash. DC). 171: 813-815.
4. Townsend, A.R.M., F.M. Gotch, and J. Davey. 1985. Cytotoxic T cells recognize fragments of the Influenza nucleoprotein. Celt. 42: 457-467.
5. Townsend, A.R.M., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44: 959-968.
6. Maryanski, J., P. Pala, G. Corradin, B. Jordan, and J. Cerottini. 1986. H-2-restricted cytolytic T-cells specific for HLA can recognize a synthetic HLA peptide. Nature (Land.). 324: 578-579.
7. Bjorkman, P.L., M.A. Saper, B. Samraoui, W.S. Bennett, J.L. Strominger, and D.C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (Land.). 329: 512-518.
8. Carbone, F.R., and M.J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169: 603-612.
9. Deres, K., H. Schild, K.H. Wiesmiiller, G. Jung, and H.G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (bond.). 342: 561-564.
10. Aichele, P., H. Hengartner, R.M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171: 1815-1820.
11. Gao, X., B. Zheng, F.Y. Liew, S. Brett, and J. Tite. 1991. Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by short synthetic peptides. J. Immunol. 147: 3268-3273.
12. Francis, M.J., G.Z. Hastings, A.D. Syred, B. McGinn, F. Brown, and D.J. Rowlands. 1987. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T cell determinants. Nature (Lond.). 300: 168-173.
13. Good, M.F., W.L. Maloy, M.N. Lunde, H. Margalit, J.L. Cornette, G.L. Smith, B. Moss, L.H. Miller, and J.A. Berzofsky. 1987. Construction of synthetic immunogen: Use of new T-helper epitope on malaria circumsporozoite protein. Science (Wash. DC). 235: 1059-1062.
14. Milich, D.R., A. McLachlan, G.B. Thornton, and J.L. Hughes. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature (Lond.). 329: 547-549.
15. Falk, K., O. Rotzschke, and H.G. Rammensee. 1990. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature (Lond.). 348: 248-251.
16. Rötzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (Lond.). 348: 252-254.
17. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351: 290-296.
18. Rudensky, A.Y., P. Preston-Hurlburt, S.-C. Hong, A. Barlow, and C.A. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature (Lond.). 353: 622-627.
19. Arnon, R., and R.J. Horwitz. 1992. Synthetic peptides as vaccines. Curr. Opin. Immunol. 4: 449-453.
20. Oki, A., and E. Sercarz. 1985. T cell tolerance studied at the level of antigenic determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice. J. Exp Med. 161: 897-911.
21. Ria, F., B.M.C. Chan, M.T. Scherer, J.A. Smith, and M.L. Gefter. 1990. Immunological activity of covalently linked Tcell epitopes. Nature (Lond.). 343: 381-383.
22. Kyburz, D., P. Aichele, D.E. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23: 1956-1962.
23. Vidard, L., L.J. Colarusso, and B. Benacerraf. 1994. Specific T-cell tolerance may be preceded by a primary response. Proc Natl. Acad. Sci. USA. 91: 5627-5631.
24. Clayton, J.P., G.M. Gammon, D.G. Ando, D.H. Kono, L. Hood, and E.E. Sercarz. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis: neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp Med. 169: 1681-1691.
25. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C.G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science (Wash. DC). 258: 1491-1494.
26. Metzler, B., and D.C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5: 1159-1165.
27. Aichele, P., D. Kyburz, P.S. Ohashi, R.M. Zinkernagel, H. Hengartner, and H. Pircher. 1994. Peptide induced T cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl. Acad. Sci. USA. 91: 444-448.
28. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Lortd.). 366: 72-75.
29. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S.P. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann. 1993. Spotaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.). 366: 69-72.
30. Briner, T.J., M.-C. Kuo, K.M. Keating, B.L. Rogers, and J.L. Greenstein. 1993. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptide from the major cat allergen Fel d I. Proc. Natl. Acad. Sci. USA. 90: 7608-7612.
31. Hoyne, G.F., R.E. O’Hehir, D.C. Wraith, W.R. Thomas, and J.R. Lamb. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp Med. 178: 1783-1788.
32. Tisch, R., and H.O. McDevitt. 1994. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity? Proc. Natl. Acad. Sci. USA. 91: 437-438.
33. Monaco, A.P., M.L. Wood, and P.S. Russel. 1966. Studies on heterologous anti-lymphocyte serum in mice. III. Immunologic tolerance and chimerism across FI-2 locus with adult thymectomy and anti-lymphocyte serum. Ann. NY Acad. Sci. 129: 190.
34. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10: 1-173.
35. Pircher, H.P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (Lond.). 346: 629-633.
36. Schulz, M., P. Aichele, M. Vollenweider, F.W. Bobe, F. Cardinaux, H. Hengartner, and R.M. Zinkernagel. 1989. MHC dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19: 1657-1667.
37. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R.M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods. 33: 191-198.
38. Zinkernagel, R.M., T.P. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp Med. 162: 2125-2141.
39. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science (Wash. DC). 169: 1042-1049.
40. Lafferty, K.J., and A.J. Cunningham. 1975. A new analysis of allogeneic interactions. Aust.J. Exp Biol. Med. Sci. 53: 27-42.
41. Warren, H.S., F.R. Vogel, and L.A. Chedid. 1986. Current status of immunological adjuvants. Annu. Rev. Immunol. 4: 369-388.
42. Jenkins, M.K. 1994. The ups and downs of T cell costimulation. Immunity. 1: 443-446.
43. Lenardo, M.J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature (Lond.). 353: 858-861.
44. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63: 1249-1256.
45. Moskophidis, D., F. Lechner, H.P. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362: 758-761.
46. Mamalaki, C., Y. Tanaka, P. Corbella, P. Chandler, E. Simpson, and D. Kioussis. 1993. T cell deletion follows chronic antigen specific T cell activation in vivo. Int. Immunol. 5: 1285-1292.
47. Kearney, E.R., K.A. Pape, D.Y. Loh, and M.K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1: 327-339.
48. Critchfield, J.M., M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, and M.J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (Wash. DC). 263: 1139-1143.
49. Kast, W.M., R. Offringa, P.J. Peters, A.C. Voordouw, R.H. Meloen, and A.J. Van Der Erb. 1989. Eradication of adenovirus El-induced tumors by ElA-specific cytotoxic T lymphocytes. Cell. 59: 603-614.
50. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wish. DC). 254: 1643-1647.
51. Feltkamp, M.C.W., H.L. Smits, M.P.M. Vierboom, R.P. Minnaar, B.M. de Jongh, J.W. Drijhout, J. ter Schegget, C.J.M. Melief, and W.M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23: 2242-2249.
52. Schulz, M., R.M. Zinkernagel, and H. Hengartner. 1991. Peptide induced antiviral protection by cytotoxic T cells. Proc Natl. Acad. Sci. USA. 88: 991-993.
53. Kast, W.M., L. Roux, J. Curren, H.J.J. Blom, A.C. Voordouw, R.H. Meloen, D. Kolakofsky, and C.J.M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl. Acad. Sci. USA. 88: 2283-2287.
54. Wolowczuk, I., C. Auriault, M. Bossus, D. Boulanger, H. Gras-Masse, C. Mazingue, R.J. Pierce, D. Grezel, G.D. Reid, A. Tartar, and A. Capron. 1991. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. J. Immunol. 146: 1987-1995.